Evidence map›Paper›PMID 42619360›Full record

ArticleAnales del sistema sanitario de Navarra2026

[Impact of an indicated prevention program on risk behaviors among adolescents at psychosocial risk].

Garikoitz Mendigutxia, José J López-Goñi

Abstract readEnglish Abstract
In one paragraph

Article in Anales del sistema sanitario de Navarra, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Garikoitz MendigutxiaPrograma Suspertu. Fundación Proyecto Hombre de Navarra. Pamplona. España.
José J López-GoñiUniversidad Pública de Navarra. Departamento de Ciencias de la Salud. Pamplona. España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndicated prevention targeting adolescents at psychosocial risk is a public health priority, yet evidence on its effectiveness in Spain remains limited. This study evaluates the impact of a preventive program on personality traits, personal competencies, psychopathological symptoms, cannabis use, and other risk behaviors.

methodsA quasi-experimental design with three assessment points (pre-intervention, post-intervention, and three-month follow-up) was used. Participants were adolescents recruited though the Suspertu Programme of Fundación Proyecto Hombre Navarra between March 2014 and June 2017. Validated instruments assessing personality, psychopathology, and risk behaviors were administered. Statistical analyses included repeated-measures general linear models, effect sizes were estimated using Cohen's d.

resultsThe sample comprised 61 adolescents (44 males, 72.1%), with a mean age of 16.7 years (SD = 2.0). Statistically significant changes were observed in personality variables and improvements in personal competencies, including self-esteem, self-efficacy, planning, and decision-making. Significant improvements were also observed across all Symptom Checklist-90-Revised dimensions at both post-intervention and follow-up. Daily cannabis use decreased from 45.5% to 4.5% among males and from 37.5% to 18.8% among females. A general reduction in other risk behaviors was also observed.

conclusionsThese findings support the effectiveness of the Suspertu Programme as an indicated prevention intervention, with positive effects maintained at three-month follow-up. The findings also underscore the importance of considering sex as a potential differentiating factor when designing and implementation indicated prevention programs.

Indexed as

Adolescent BehaviorRisk-TakingAdolescentFemaleHumansMaleProgram Evaluation

Identifiers

PMID42619360
PMCPMC13548298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.